The text starts here.

News Release

FOR IMMEDIATE RELEASE
July 2, 2002

EISAI LAUNCHES TRAVELMINR FAMILY
- A MOTION SICKNESS MEDICATION THAT DISSOLVES QUICKLY IN THE MOUTH -

Tokyo (July 2, 2002) - Eisai Co., Ltd. of Tokyo (President and CEO: Haruo Naito) announced the July 3rd launch of TRAVELMINR FAMILY, a motion sickness medication that dissolves quickly in the mouth without water.


TRAVELMINR FAMILY is beneficial for the prevention and relief of motion sickness and can be taken by adults and children over age 5.


The TRAVELMINR FAMILY tablet dissolves quickly in the mouth and its inherent bitterness is masked. TRAVELMINR FAMILY can be taken during transit such as on the bus or in the train without water. TRAVELMINR FAMILY should be taken half an hour prior to travel for the prevention of motion sickness, however, it is also beneficial after symptoms have appeared.


Eisai launched the original TRAVELMINR in 1952 and has marked the 50th anniversary of the TRAVELMINR brand. Eisai will continue to meet various motion sickness needs.


TRAVELMIN(R) FAMILY

For additional information about TRAVELMINR FAMILY and the Company's other healthcare products, please contact Eisai's consumer hotline.


Toll Free Number (in Japan): 0120-161-454.
Monday-Friday 9 a.m. - 6 p.m.
Saturday/Sunday/Holiday 9 a.m. - 5 p.m.


Eisai Co., Ltd. is a research based human healthcare company which discovers, develops and markets products in more than 30 countries. Through a global network of research facilities, manufacturing sites and marketing subsidiaries, Eisai actively participates in all aspects of the worldwide healthcare system. The company reported sales of over $3.2 billion in 2001 with approximately 13 percent of sales spent for research and development.